Published October 3, 2022
| Version v1
Journal article
Open
Bromhidrato de pivoxil de tebipenem por vía oral en la infección urinaria complicada
- 1. Servicio Medicina Interna (Unidad de Enfermedades Infecciosas). Hospital Universitario HM Sanchinarro, Madrid
Description
Existe la necesidad de disponer de antibióticos orales que sean efectivos frente a microorganismos gram negativos multirresistentes. Tebipenem es un carbapenémico oral con actividad frente a enterobacterias, incluyendo a betalactamasas de espectro extendido y patógenos resistentes a fluoroquinolonas.
Files
Bromhidrato de pivoxil de tebipenem por vía oral.pdf
Files
(294.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:33650760741767a125aa670259724800
|
294.2 kB | Preview Download |
Additional details
References
- Vol 21 Nº6; págs. 637-644. 2020. Bientinesi R, Murri R, Sacco E. Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis. Expert Opinion on Pharmacotherapy. DOI: https://doi.org/10.1080/14656566.2020.1720647
- Vol 7 Nº2; págs. Derington CG, Benavides N, Delate T, Fish DN. Multiple-dose oral fosfomycin for treatment of complicated urinary tract infections in the outpatient setting. Open Forum Infectious Diseases. DOI: https://doi.org/10.1093/ofid/ofaa034
- Vol 12 Nº6; págs. 843-846. 2019. Raja NS. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae. DOI: https://doi.org/10.1016/j.jiph.2019.05.012
- Vol 63 Nº6; pág. 20618. 2019. Arends SJR, Rhomberg PR, Cotroneo N, Rubio A, Flamm RK, Mendes RE. Antimicrobial Activity Evaluation of Tebipenem (SPR859), an Orally Available Carbapenem, against a Global Set of Enterobacteriaceae Isolates, Including a Challenge Set of Organisms. Antimicrobial Agents and Chemotherapy. DOI: https://doi.org/10.1128/AAC.02618-18